Clinical Trials on Glabellar Crease

Total 10000 results

‹
1
2
...
107
108
109
110
111
112
113
...
199
200
›

Institut Paoli-Calmettes
GlaxoSmithKline

Not yet recruiting

A Phase 1b/2 Trial Evaluating Safety and Efficacy of CAPecitabine in Combination With Ni-rapaRIb in HER2-negative Advanced Breast canCEr (CAPRICE)

Breast Cancer
The Affiliated Hospital of Qingdao University
Jiangsu HengRui Medicine Co., Ltd.

Not yet recruiting

Neoadjuvant Dalpiciclib Plus Letrozole for HR+/HER2- Breast Cancer

Breast Cancer
Jiangsu Hansoh Pharmaceutical Co., Ltd.

Recruiting

A Phase Ib Study of HS-10352 Plus Fulvestrant in Patients With Advanced Breast Cancer

Breast Cancer

China
Columbia University
National Institute on Minority Health and Health Disparities (NIMHD)

Recruiting

IMPACT Trial: Intervention to iMProve AdherenCe Equitably

Breast Cancer

United States
Pierre Fabre Medicament

Not yet recruiting

Treatment Patterns of Neratinib in HER2+ EBC in China

Breast Cancer

China
Ruijin Hospital

Recruiting

RapidPlan Models Establishment for Node-Positive Breast Cancer Treated With Hypofractionation Using Edge/Truebeam

Breast Cancer

China
Biyun Wang, MD

Recruiting

Chidamide in Combination With Abemaciclib and Endocrinotherapy（Doctor's Choice） in Breast Cancer Patients Previously Treated With Palbociclib (CINDERELLA)

Breast Cancer

China
University of Erlangen-Nürnberg Medical School

Not yet recruiting

Postoperative Radiation of Patients With Breast Cancer in Extreme Hypofractionation.

Breast Cancer
Institut Curie

Recruiting

Opioid Free Versus Opioid Based Anaesthesia for Free Flap Reconstruction Surgery of the Breast: A Phase III Multicentric Randomized Controlled Study. (OFOBA)

Breast Cancer

France
Assiut University

Recruiting

The Role of Lipofilling After Oncoplastic Breast Surgeries : Evaluation of Outcomes and Patient Satisfaction

Cancer, Breast

Egypt
Second Affiliated Hospital, School of Medicine,...

Recruiting

A Study for the Adjuvant Treatment of Breast Cancer

Breast Cancer

China
wang shusen

Recruiting

Tucidinostat Combined With Metronomic Capecitabine and Endocrine Therapy for Advanced HR-positive, HER2-negative Breast Cancer After CDK4/6 Inhibitor.

Breast Cancer

China
Fudan University

Recruiting

Sintilimab and Bevacizumab Biosimilar Combined With PLD in mTNBC

Breast Cancer

China
Jiangsu HengRui Medicine Co., Ltd.

Recruiting

A Phase Ib/II Study of SHR-A1811 Injection in Breast Cancer

Breast Cancer

China
Maastricht Radiation Oncology
Maastricht University Medical Center; Maastricht University

Recruiting

Developing Breast (Cancer) Organoids

Breast Cancer

Netherlands
Novartis Pharmaceuticals

Recruiting

A Post Marketing Surveillance on Piqray in Korea

Breast Cancer

Korea, Republic of
Cancer Institute and Hospital, Chinese Academy...

Not yet recruiting

Inetetamab Combined With Anti-PD-1 Monoclonal Antibody and Albumin-Bound Paclitaxel for HER2+ Metastatic Breast Cancer

Breast Cancer

China
University of Utah

Recruiting

Feasibility Evaluation of the Muse Magnetic Resonance Guided Focused Ultrasound System (BreastMRgFUS)

Breast Cancer

United States
Cancer Institute and Hospital, Chinese Academy...
CSPC Ouyi Pharmaceutical Co., Ltd.

Not yet recruiting

Adjuvant Albumin-bound Paclitaxel Versus Taxanes in Breast Cancer: a Real-world Study

Breast Cancer

China
Shengjing Hospital

Recruiting

Axillary Lymph Node Treatment Guided by Naocarbon Tracing After Neoadjuvant Chemotherapy

Breast Cancer

China
Liaoning Tumor Hospital & Institute

Not yet recruiting

Clinical Study of Fulvestrant Combined With Chidamide in the Treatment of Hormone Receptor-positive Advanced Breast Cancer Resistant to CDK4/6 Inhibitors

Breast Cancer
Karolinska Institutet

Recruiting

Physical Exercise During Preoperative Chemotherapy for Breast Cancer (Neo-ACT)

Breast Cancer

Sweden, Finland, Australia, United Kingdom
Endomagnetics Ltd.

Recruiting

Magseed Pro(R)/ Sentimag(R) Gen3

Breast Cancer

Germany, United Kingdom
Tianjin Hemay Oncology Pharmaceutical Co., Ltd

Recruiting

A Phase Ⅲ Study of the Efficacy and Safety of Hemay022+Aromatase Inhibitor(AI) in Participants With ER+/HER2+ Advanced or Metastatic Breast Cancer (Fillful-03)

Breast Cancer

China
Beni-Suef University

Recruiting

Study of the Therapeutic Effect of Atorvastatin on the Clinical Outcomes in HER2 Negative Breast Cancer Patients"

Breast Cancer

Egypt
University of Florida

Recruiting

Pharmacokinetics and Safety of Epidiferphane and Taxanes in Breast Cancer Patients

Breast Cancer

United States
Cancer Institute and Hospital, Chinese Academy...

Recruiting

Hypofractionated Post Mastectomy Radiation With Two-Stage Expander/Implant Reconstruction

Breast Carcinoma

China
M.D. Anderson Cancer Center

Recruiting

Comparative Performance of Molecular Breast Imaging (MBI) to Magnetic Resonance Imaging (MRI) of the Breast in Identifying and Excluding Breast Carcinoma in Women at High Risk for Breast Cancer

Breast Cancer

United States
Hospital Italiano de Buenos Aires

Not yet recruiting

Multicentric Study for External Validation of a Deep Learning Model for Mammographic Breast Density Categorization

Breast Cancer
Sun Yat-sen University

Recruiting

Fulvestrant Plus Anlotinib in HR(+)/HER2(-) Metastatic Breast Cancer With FGFR Mutation

Breast Cancer

China
Centre Georges Francois Leclerc

Recruiting

Immunomonitoring of Breast Cancer Patients During Systemic Treatment (IMMUNE CAPTURE)

Breast Cancer

France
West China Hospital

Recruiting

Single-arm, Multi-center Clinical Study of Pyrotinib Maleate Tablets Combined With Albumin-bound Paclitaxel and Trastuzumab in Neoadjuvant Treatment of Her2-positive Early or Locally Advanced Breast Cancer

Breast Cancer

China
Centre Hospitalier Universitaire de Besancon

Recruiting

Supervised Exercise, Sleep in Patients With Non Metastatic Breast Cancer (FATSOMCAN)

Breast Cancer

France
Columbia University
National Cancer Institute (NCI)

Recruiting

Breast Elasticity Imaging During Neoadjuvant Chemotherapy

Breast Cancer

United States
Fudan University

Recruiting

Study on the Value of Non-invasive Dual-Pet Information in Subtype of Metastatic Breast Cancer

Breast Cancer

China
Jiuda Zhao

Recruiting

Efficacy and Safety of Sintilimab and Apatinib Combined Chemotherapy in Breast Cancer

Breast Cancer

China
The First Affiliated Hospital with Nanjing Medical...

Recruiting

Pyrotinib as Neoadjuvant Agent for Non-objective Response HER2-positive Early Breast Cancer

Breast Cancer

China
Mansoura University

Not yet recruiting

Efficacy of Statin Addition to Neoadjuvant Chemotherapy Protocols for Breast Cancer

Breast Cancer

Egypt
Mayo Clinic
United States Department of Defense

Recruiting

3D Ultrasound Breast Imaging

Breast Tumor

United States
Ying Wang

Recruiting

The Establishment of a Survival Prediction Model for ER Positive / HER-2 Negative Advanced Breast Cancer

Breast Cancer

China
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Recruiting

Efficacy and Safety of Eribulin in the Treatment of Advanced Breast Cancer

Breast Cancer

China
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Recruiting

Inetetamab Combined With Pyrotinib and Chemotherapy in the Treatment of HER2 Positive Metastatic Breast Cancer

Breast Cancer

China
European Institute of Oncology

Recruiting

Single Fraction Preoperative Radiotherapy for Early Stage Breast Cancer

Breast Cancer

Italy
University of Texas Southwestern Medical Center
Eli Lilly and Company; Cancer Prevention Research Institute of Texas

Recruiting

Single Cell Immune and Non-immune Correlates of Response to Neoadjuvant Abemaciclib

Breast Cancer

United States
Latin American Cooperative Oncology Group
Grupo Brasileiro de Estudos do Câncer de Mama (GBECAM)

Recruiting

Evaluation of Sequencing of Anthracyclines and Taxanes for Locally Advanced HER2-negative Breast Cancer (NEOSAMBA)

Breast Cancer

Brazil
Fudan University

Recruiting

First-line Nab-paclitaxel Plus Cisplatin Plus Carilizumab in mTNBC Patients

Breast Cancer

China
Ruijin Hospital

Recruiting

Evaluating Omitting of Internal Mammary Irradiation Among Early Stage Intermediate Risk (N1) Breast Cancer

Breast Cancer

China
Fudan University

Recruiting

A Trial Evaluating the Efficacy of Metastasectomy in Patients With Oligo-Metastatic Breast Cancer(OMIT)

Breast Cancer

China
Turku University Hospital

Recruiting

Exercise and Tumor Blood Flow in Breast Cancer Patients (EXETUMOR2)

Cancer, Breast

Finland
Mansoura University

Recruiting

Neoadjuvant Chemotherapy With or Without Metformin in Early Breast Cancer.

Breast Cancer

Egypt

‹
1
2
...
107
108
109
110
111
112
113
...
199
200
›

Subscribe